| Product NDC: | 63739-535 | 
| Proprietary Name: | Pramipexole Dihydrochloride | 
| Non Proprietary Name: | Pramipexole Dihydrochloride | 
| Active Ingredient(s): | .5 mg/1 & nbsp; Pramipexole Dihydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 63739-535 | 
| Labeler Name: | McKesson Packaging Services a business unit of McKesson Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA091254 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120622 | 
| Package NDC: | 63739-535-10 | 
| Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-535-10) > 10 TABLET in 1 BLISTER PACK | 
| NDC Code | 63739-535-10 | 
| Proprietary Name | Pramipexole Dihydrochloride | 
| Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-535-10) > 10 TABLET in 1 BLISTER PACK | 
| Product NDC | 63739-535 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Pramipexole Dihydrochloride | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20120622 | 
| Marketing Category Name | ANDA | 
| Labeler Name | McKesson Packaging Services a business unit of McKesson Corporation | 
| Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE | 
| Strength Number | .5 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |